Intracellular expression of P-170 glycoprotein in peripheral blood mononuclear cell subsets from healthy donors and HIV-infected patients.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Haematologica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 9542318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of the multidrug resistance gene in human tumors.

  2014cited by this paper
• Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells

  2012cited by this paper
• P‐glycoprotein epitope mapping. I. Identification of a linear human‐specific epitope in the fourth loop of the P‐glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi‐drug‐resistant cells

  2007cited by this paper
• Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells

  2005cited by this paper
• Multidrug resistance in leukemia

  1998cited by this paper
• Plasma cell P170 expression and response to treatment in multiple myeloma.

  1996cited by this paper
• Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin.

  1996cited by this paper
• Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.

  1996cited by this paper
• Involvement of cytoplasmic factors regulating the membrane orientation of P-glycoprotein sequences.

  1995cited by this paper
• P-glycoprotein expression in acute myeloblastic leukemia analyzed by immunocytochemistry and flow cytometry.

  1995cited by this paper
• Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: implications for treatment.

  1995cited by this paper
• Transmembrane P-Glycoprotein (P-gp/P-170) in HIV Infection: Analysis of Lymphocyte Surface Expression and Drug-Unrelated Function

  1995cited by this paper
• Cell surface expression of major histocompatibility class I antigens is modulated by P-glycoprotein transporter.

  1995cited by this paper
• Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine a analogs

  1995cited by this paper
• Regulation of protein kinase C and role in cancer biology

  1994cited by this paper
• P‐glycoprotein expression in the Golgi apparatus of multidrug‐resistant cells

  1994cited by this paper
• High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias.

  1994cited by this paper
• Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma.

  1994cited by this paper
• P-glycoprotein (MDR 1 gene product) in cells of the immune system: Its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection

  1993cited by this paper
• Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphocytic leukaemia and correlation with in vitro drug resistance.

  1993cited by this paper
• Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.

  1992cited by this paper
• Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.

  1992cited by this paper
• Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistance.

  1992cited by this paper
• Multidrug resistance in leukaemia.

  1992cited by this paper
• Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8 + T cells: A role in cytotoxic effector function

  1992cited by this paper
• Integrins: versatility, modulation, and signaling in cell adhesion.

  1992cited by this paper
• Resistance of HIV-1 to AZT Might Also Involve the Cellular Expression of Multidrug Resistance P-Glycoprotein

  1992cited by this paper
• Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones

  1991cited by this paper
• Multidrug resistance activity in human lymphocytes.

  1991cited by this paper
• The expression of the multidrug resistance‐associated glycoprotein in B‐cell chronic lymphocytic leukaemia

  1991cited by this paper
• Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cells.

  1990cited by this paper
• Expression of the multiple drug resistance gene (mdr‐1) and epitope masking in chronic lymphatic leukaemia

  1990cited by this paper
• Transport protein genes in the murine MHC: possible implications for antigen processing.

  1990cited by this paper
• P‐glycoprotein: multidrug‐resistance and a superfamily of membrane‐associated transport proteins

  1989cited by this paper
• The direct activation of human multidrug resistance gene (MDR1) by anticancer agents.

  1989cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• Lymphocyte activation by HIV-1 envelope glycoprotein

  1988cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper
• Expression of a multidrug-resistance gene in human tumors and tissues.

  1987cited by this paper

• Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans

  2017cites this paper
• Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

  2015cites this paper
• Interference of flavonoids with fluorescent intracellular probes: Methodological implications in the evaluation of the oxidative burst by flow cytometry

  2014cites this paper
• The cellular pharmacokinetics of HIV protease inhibitors: current knowledge and future perspectives.

  2012cites this paper
• Impact of ATP-binding cassette transporters on human immunodeficiency virus therapy.

  2010cites this paper
• Intact Lipid Rafts Regulate HIV-1 Tat Protein-Induced Activation of the Rho Signaling and Upregulation of P-Glycoprotein in Brain Endothelial Cells

  2010cites this paper
• ABC transporters in human lymphocytes: expression, activity and role, modulating factors and consequences for antiretroviral therapies

  2010cites this paper
• Glucoproteína P e infección por el virus de la inmunodeficiencia humana

  2008cites this paper
• [P-glycoprotein and human immunodeficiency virus infection].

  2008cites this paper
• Regulation of ABC membrane transporters in glial cells: Relevance to the pharmacotherapy of brain HIV‐1 infection

  2008cites this paper
• Expression of Adenosine Triphosphate-Binding Cassette (ABC) Drug Transporters in Peripheral Blood Cells

  2007cites this paper
• Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.

  2006cites this paper
• Therapeutic strategies towards HIV-1 infection in macrophages.

  2006cites this paper
• Mechanisms underlying activity of antiretroviral drugs in HIV‐1‐infected macrophages: new therapeutic strategies

  2006cites this paper
• Chapter 18 P-glycoproteins and xenobiotic efflux transport in fish

  2005cites this paper
• HIV‐Tat protein induces P‐glycoprotein expression in brain microvascular endothelial cells

  2005cites this paper
• P-Glycoprotein-based drug-drug interactions: preclinical methods and relevance to clinical observations

  2004cites this paper
• The Role of Diet in Modulating Gut Detoxification Mechanisms

  2004cites this paper
• Functional Expression and Localization of P-glycoprotein in the Central Nervous System: Relevance to the Pathogenesis and Treatment of Neurological Disorders

  2004cites this paper
• What Is Going on with Natural Killer Cells in HIV Infection?

  2004cites this paper
• Antiviral profile of HIV inhibitors in macrophages: implications for therapy.

  2004cites this paper
• The Expression of P-Glycoprotein and Cellular Kinases Is Modulated at the Transcriptional Level by Infection and Highly Active Antiretroviral Therapy in a Primate Model of AIDS

  2003cites this paper
• A simplified approach to determining P-glycoprotein expression in peripheral blood mononuclear cell subsets.

  2003cites this paper
• Differential effects of p-glycoprotein and multidrug resistance protein-1 on productive human immunodeficiency virus infection.

  2002cites this paper
• In vitro and in vivo modulation of MDR1/P-glycoprotein in HIV-infected patients administered highly active antiretroviral therapy and liposomal doxorubicin.

  2002cites this paper
• Up-Regulation of Drug Resistance-Related Vaults During Dendritic Cell Development1

  2002cites this paper
• Intracellular pharmacology of nucleoside analogues and protease inhibitors: role of transporter molecules

  2002cites this paper
• Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir.

  2002cites this paper
• Vaults During Dendritic Cell Development Up-Regulation of Drug Resistance-Related

  2002cites this paper
• Short Communication: Expression of P-Glycoprotein and Multidrug Resistance-Associated Protein in Healthy Volunteers and HIV-Infected Patients

  2001cites this paper
• Expression of P-glycoprotein and multidrug resistance-associated protein in healthy volunteers and HIV-infected patients.

  2001cites this paper
• Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport

  2001cites this paper
• Expression of P-glycoprotein in the chicken.

  2001cites this paper
• HIV‐Protease Inhibitors Contribute to P‐Glycoprotein Efflux Function Defect in Peripheral Blood Lymphocytes From HIV‐Positive Patients Receiving HAART

  2001cites this paper
• Activities of Masked 2′,3′-Dideoxynucleoside Monophosphate Derivatives against Human Immunodeficiency Virus in Resting Macrophages

  2000cites this paper
• [Evaluation of the effect of early and massive tritherapy on the expression of cellular factors potentially implicated in antiretroviral therapy resistance].

  2000cites this paper
• Cellular factors involved in the induction of resistance of HIV to antiretroviral agents.

  2000cites this paper
• Short Communication Expression of P-Glycoprotein and Multidrug Resistance-Associated Protein in Healthy Volunteers and HIV-Infected Patients

  year unknowncites this paper